Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2022-12-09 Sale | 2022-12-13 8:26 pm | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 13,799 | $1.0959 | $15,123 | 232,717 (Direct) | View |
| 2022-12-07 Sale | 2022-12-09 4:53 pm | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 7,942 | $1.2694 | $10,081 | 254,458 (Direct) | View |
| 2022-12-05 Sale | 2022-12-07 7:56 pm | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 7,464 | $1.3518 | $10,090 | 269,864 (Direct) | View |
| 2022-12-02 Sale | 2022-12-05 7:52 pm | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 3,636 | $1.39 | $5,054 | 203,026 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-01-24 Option Award | 2024-01-25 4:04 pm | N/A 2034-01-23 | Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer | 60,000 | $3.06 | 60,000 (Direct) | View |
| 2023-09-11 Option Award | 2023-09-13 4:01 pm | N/A 2033-09-10 | Foghorn Therapeutics Inc. | FHTX | Cardama Alfonso Quintas Chief Medical Officer | 272,000 | $7.57 | 272,000 (Direct) | View |
| 2023-06-01 Disposition | 2023-06-01 4:29 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 488,678 | $0 | 0 (Direct) | View |
| 2022-12-15 Option Award | 2022-12-19 5:44 pm | N/A 2032-12-14 | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 82,424 | $0 | 191,883 (Direct) | View |
| 2022-12-01 Exercise | 2022-12-05 7:52 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 190,770 | $0 | 203,026 (Direct) | View |
| 2022-11-17 Disposition | 2022-11-18 4:38 pm | N/A 2029-04-10 | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 384,402 | $0 | 159,747 (Direct) | View |
| 2022-11-17 Option Award | 2022-11-18 4:38 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 112,832 | $0 | 159,747 (Direct) | View |
| 2021-12-09 Exercise | 2021-12-10 4:34 pm | N/A 2027-10-09 | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 43,000 | $0.74 | 193,197 (Direct) | View |
| 2021-08-31 Option Award | 2021-12-10 4:34 pm | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 164 | $14.26 | 193,197 (Direct) | View |
| 2021-12-09 Option Award | 2021-12-10 4:34 pm | N/A 2031-12-08 | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 114,700 | $0 | 193,197 (Direct) | View |
| 2020-08-31 Option Award | 2021-03-08 08:20 am | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 1,118 | $10.1 | 3,751 (Direct) | View |
| 2021-02-28 Option Award | 2021-03-08 08:20 am | N/A N/A | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 708 | $16.12 | 3,751 (Direct) | View |
| 2020-12-10 Option Award | 2020-12-11 06:19 am | N/A 2030-12-09 | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 101,000 | $0 | 102,925 (Direct) | View |
| 2019-12-19 Option Award | 2019-12-20 7:45 pm | N/A 2029-12-18 | TCR2 THERAPEUTICS INC. | TCRR | Cardama Alfonso Quintas Chief Medical Officer | 72,100 | $0 | 72,100 (Direct) | View |